Clinical Trials Directory

Trials / Unknown

UnknownNCT04791046

Antihypertensive Therapy in Patients With Comorbidities

Personalized Evidence-based Medicine Improves Outcomes of Antihypertensive Therapy in Patients With Comorbidities

Status
Unknown
Phase
Study type
Observational
Enrollment
100,000 (estimated)
Sponsor
Center of Personalized Medicine, Pirogova · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A retrospective analysis

Detailed description

This retrospective study will be performed using all-Russian nationwide database of anonymized medical health claims and administrative data. The database holds information on diagnoses, patient data, medications, results of examinations, laboratory values, and genomic information, visits, follow up and outcomes. Participating health care organizations include a mix of hospital, primary care, and specialty treatment providers spanning a wide range of geographies, age groups, and income levels. This study will analyze of outcomes according to comorbidity and antihypertensive drug prescriptions. The study will include patients who were first diagnosed with hypertension, attended the hospital as an outpatient due to hypertension, and received their antihypertensive prescription as an outpatient. To be eligible for inclusion, patients must have had comorbidities and outpatient visits or hospitalizations (for any indication) during the 3-years. The study will focused on comorbidities for choice of antihypertensive drug therapy: diabetes mellitus, dyslipidemia, gout/hyperuricemia, heart diseases, cerebrovascular diseases, and renal diseases. We going to analyze the EMR of patients who had hypertension and comorbidities by CDSS (MedicBK) utilizing a core laboratory.

Conditions

Interventions

TypeNameDescription
DRUGantihypertensive therapyPersonalized evidence-based antihypertensive therapy in patients with comorbidities

Timeline

Start date
2021-02-01
Primary completion
2021-03-30
Completion
2021-03-30
First posted
2021-03-10
Last updated
2021-03-11

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04791046. Inclusion in this directory is not an endorsement.